Quarterly report [Sections 13 or 15(d)]

Condensed Statement of Changes in Stockholders' Equity (Unaudited) (Unaudited)

v3.26.3
Condensed Statement of Changes in Stockholders' Equity (Unaudited) (Unaudited) - USD ($)
$ in Thousands
Total
At The Market Offering
Common Stock
Common Stock
At The Market Offering
Additional Paid-in Capital
Additional Paid-in Capital
At The Market Offering
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024     26,960,901        
Beginning balance at Dec. 31, 2024 $ 1,654   $ 3   $ 57,924   $ (56,273)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation expense 3,720       3,720    
Sale of Common Stock, net of issuance costs (in shares)     6,746,386 313,476      
Sale of Common Stock, net of issuance costs 10,250 $ 494   $ 1 10,250 $ 493  
Stock issuance upon exercise of stock options (in shares)     50,532        
Stock issuance upon exercise of stock options 1       1    
Stock issuance upon vesting of restricted stock units (in shares)     269,432        
Net loss (15,713)           (15,713)
Ending balance (in shares) at Sep. 30, 2025     34,340,727        
Ending balance at Sep. 30, 2025 406   $ 4   72,388   (71,986)
Beginning balance (in shares) at Jun. 30, 2025     34,020,340        
Beginning balance at Jun. 30, 2025 4,182   $ 4   70,909   (66,731)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation expense 1,433       1,433    
Sale of Common Stock, net of issuance costs (in shares)       29,138      
Sale of Common Stock, net of issuance costs   $ 45       45  
Stock issuance upon exercise of stock options (in shares)     21,817        
Stock issuance upon exercise of stock options 1       1    
Stock issuance upon vesting of restricted stock units (in shares)     269,432        
Net loss (5,255)           (5,255)
Ending balance (in shares) at Sep. 30, 2025     34,340,727        
Ending balance at Sep. 30, 2025 $ 406   $ 4   72,388   (71,986)
Beginning balance (in shares) at Dec. 31, 2025 40,117,404   40,117,404        
Beginning balance at Dec. 31, 2025 $ 2,603   $ 4   79,887   (77,288)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation expense $ 3,855       3,855    
Sale of Common Stock, net of issuance costs (in shares) 14,375,000 970,467 14,375,000 970,467      
Sale of Common Stock, net of issuance costs $ 10,265 $ 1,515 $ 2   10,263 $ 1,515  
Stock issuance upon exercise of stock options (in shares) 35,000   35,000        
Stock issuance upon exercise of stock options $ 10       10    
Stock issuance upon vesting of restricted stock units (in shares)     1,902,770        
Stock issuance upon vesting of restricted stock units 915       915    
Stock issuance upon settlement of liability, (in shares)     112,360        
Stock issuance upon settlement of liability 100       100    
Net loss $ (12,749)           (12,749)
Ending balance (in shares) at Sep. 30, 2026 57,513,001   57,513,001        
Ending balance at Sep. 30, 2026 $ 6,514   $ 6   96,545   (90,037)
Beginning balance (in shares) at Jun. 30, 2026     56,349,171        
Beginning balance at Jun. 30, 2026 8,177   $ 6   95,198   (87,027)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation expense 937       937    
Stock issuance upon vesting of restricted stock units (in shares)     1,163,830        
Stock issuance upon vesting of restricted stock units 410   $ 0   410    
Net loss $ (3,010)           (3,010)
Ending balance (in shares) at Sep. 30, 2026 57,513,001   57,513,001        
Ending balance at Sep. 30, 2026 $ 6,514   $ 6   $ 96,545   $ (90,037)